


The aim of the Fund is to provide a growing income with capital growth.
| Name | % Net Assets |
|---|---|
| Vodafone Group PLC | 5.3% |
| GlaxoSmithKline PLC | 4.5% |
| Royal Dutch Shell PLC (CL B) | 4.3% |
| BP PLC | 3.9% |
| AstraZeneca PLC | 2.9% |
| National Grid PLC | 2.7% |
| British American Tobacco PLC | 2.6% |
| Scottish & Southern Energy PLC | 2.5% |
| Imperial Tobacco Group PLC | 2.3% |
| RSA Insurance Group PLC | 2.0% |
| Key | % Net Assets |
|---|---|
| 5.3% | |
| 4.5% | |
| 4.3% | |
| 3.9% | |
| 82% |
| Date | 09-Apr-2021 |
|---|---|
| Bid | 81.12p |
| Offer | 81.12p |
| Currency | GBP |
| Change | 0.13p |
| % | 0.16% |
| YTD change | 81.12p |
| YTD % | n/a |
| Fund Inception | 26/08/1997 |
|---|---|
| Fund Manager | Chris White |
| TER | - |
| Minimum Investment | |
|---|---|
| Initial | £500000 |
| Additional | n/a |
| Savings | n/a |
| Charges | |
|---|---|
| Initial | n/a |
| Annual Mang't | 1.25% |
| Exit | n/a |
| Name | % |
|---|---|
| Standard deviation | 0.01 |
| Sharpe ratio | 0.07 |
You are here: research